Google’s Alphabet Spins Off Life Sciences To Verily To Detect Cancer

In what appears to be a strategic move to diversify its business, Alphabet Inc has relaunched its Life Sciences division as a new spinoff company known as Verily. In an introductory video, former Google showed that Verily will be focusing more on health sciences and how it will provide solutions or studies to combat or manage diseases, the Verge notes. Its standalone website, verily.com, is also live as well.

"As a life sciences team within Google[x], we were able to combine the best of our technology heritage with expertise from across many fields. Now, as an independent company, Verily is focused on using technology to better understand health, as well as prevent, detect, and manage disease," the website read.

Endgadget said that the new Verily is working on more wearables, among other projects, to achieve their goals. One goal is reportedly using wearables to detect cancer cells at very early stages in patients. Verily is also targeting to partner with third-party firms who have the technology to help the former achieve its goals.